Enveric Biosciences Inc vs Under Armour Inc Class A — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Under Armour Inc Class A trades at $6.9 (market cap $2.89B). The key difference: Under Armour Inc Class A is far larger — about 543.2× Enveric Biosciences Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | UA | |
|---|---|---|
Market Cap | $5.32M | $2.89B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $7.88 |
52-Week Low | $1.28 | $3.96 |
Enterprise Value | $408.82K | $4.52B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UA) trades at $6.915, up 6.88% today, with a bullish technical signal from moving averages and oscillators. The company reported a net loss of -$201.27 million in 2025, with a negative net income margin of -9.98%, though it beat earnings expectations in two of the last three quarters. Recent news includes a Dodge collaboration and a 1.2 million share purchase by Prem Watsa's Fairfax Financial, signaling institutional interest amid ongoing business restructuring.
The outlook remains challenged by declining revenues and persistent losses, but low P/S of 0.58 and analyst buy ratings (40.3%) suggest potential if turnaround efforts gain traction. Key risks include execution missteps, competitive pressure, and further revenue erosion, requiring careful monitoring of 2027 guidance for sustainable recovery.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →